Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like Framingham 10-Year Cardiovascular Risk Score frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the Framingham 10-Year Cardiovascular Risk Score?
The Framingham 10-Year Cardiovascular Risk Score is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in cardiology practice. The Framingham Risk Score is a sex-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. It evaluates age, lipid panel values, blood pressure, antihypertensive treatment, smoking status, and diabetes. Clinical scoring tools like Framingham 10-Year Cardiovascular Risk Score are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
One of the most foundational and historically impactful risk stratification models used worldwide to initiate preventive cardiovascular pharmacotherapy.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate Framingham 10-Year Cardiovascular Risk Score:
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 9.9 | Low 10-Year CVD Risk (< 10%) | green |
| 10 – 19.9 | Intermediate 10-Year CVD Risk (10 - 20%) | yellow |
| ≥ 20 | High 10-Year CVD Risk (≥ 20%) | red |
When to Exercise Caution
Validated primarily in Caucasian cohorts; may underestimate risk in South Asian or high-risk ethnic groups, and does not incorporate family history or CAC score.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-07
Peer-Reviewed Medical Literature
- •D’Agostino RB Sr, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753.
Related Cardiology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Cardiology:
CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
Calculates stroke risk for patients with atrial fibrillation.
HAS-BLED Score
Assesses bleeding risk in patients on anticoagulation therapy.
Mean Arterial Pressure (MAP)
Calculate MAP based on Systolic and Diastolic Blood Pressure.
HEART Score for Major Cardiac Events
Predicts 6-week risk of major adverse cardiac events (MACE).
Wells' Criteria for Pulmonary Embolism
Calculates the pre-test probability of Pulmonary Embolism (PE).
TIMI Risk Score for UA/NSTEMI
Estimates 14-day mortality, new MI, or urgent revascularization risk in UA/NSTEMI.
Gulf Medical Licensing & Prometric Exam Preparation Network
Clinical calculations like Framingham 10-Year Cardiovascular Risk Score are essential knowledge across Gulf health licensing authorities. Review official exam blueprints, verify pass marks (SMLE: 70%), and access free practice test engines: